Sensitive and selective electrochemical sensor for palbociclib, a highly selective CDK4/6 inhibitor, based on molecularly imprinted polymer

Abstract

In this research, a molecularly imprinted polymer (MIP)-based electrochemical sensor was developed for the first time to determine palbociclib (PLB), an oral, selective Cyclin Dependent Kinase (CDK4 and CDK6) inhibitor used in the treatment of breast cancer. Acrylamide (ACR) was selected as the functional monomer to fabricate the proposed sensor (ACR-PLB-MIP/GCE), and polymerization was performed by photopolymerization. To improve the efficiency of the MIP-based electrode for PLB measurement, several factors, including monomer ratio, removal time, removal agent, and rebinding time, were carefully optimized. Under optimal conditions and using the differential pulse voltammetry (DPV) technique, the limit of detection (LOD) of 1.35 × 10−12 M and the limit of quantification (LOQ) of 4.48 × 10−12 M were calculated for PLB analysis using ACR-PLB-MIP/GCE in standard solution. Application of the ACR-PLB-MIP/GCE sensor to commercial serum samples resulted in LOD and LOQ values of 3.33 × 10−12 M and 1.11 × 10−11 M, respectively. The sensor was also applied to the tablet sample for the detection of PLB and a satisfactory RSD% (0.95) was obtained. The results of interference studies confirmed the high selectivity of the electrode for PLB analysis. These results clearly demonstrated that the molecular imprinting approach for the detection of PLB in the novel sensor system is a highly efficient approach.